I would be interested in learning whether, or not, this making the alpha-interferon product available for use under these limited circumstances is likely to generate any useful quantity of income,....
Some hard, if estimated numbers, might be good to see is what I am trying to say here.
But yes - in the long-run, this is hard to view as anything negative currently, or into the foreseeable future for HEB.
Especially if the newly revamped production facility is going to be of any use to HEB - there has to be a somewhat predictable market for the products.
News 
Market Data 
Discover 
